Reversible Myocardial Edema Secondary to Tagraxofusp-Induced Capillary Leak Syndrome

Elie N Mouhayar; Danielle Hammond; Juan Lopez-Mattei; Jose Banchs; Marina Konopleva; Naveen Pemmaraju

doi:10.1016/j.jaccao.2021.09.009

Reversible Myocardial Edema Secondary to Tagraxofusp-Induced Capillary Leak Syndrome

JACC CardioOncol. 2021 Dec 21;3(5):752-755. doi: 10.1016/j.jaccao.2021.09.009. eCollection 2021 Dec.

Authors

Elie N Mouhayar¹, Danielle Hammond², Juan Lopez-Mattei¹, Jose Banchs³, Marina Konopleva², Naveen Pemmaraju²

Affiliations

¹ Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
³ Department of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA.

No abstract available

Keywords: BPDCN, blastic plasmacytoid dendritic cell neoplasm; CLS, capillary leak syndrome; CMR, cardiovascular cardiac magnetic resonance; DT, diphtheria toxin; ECV, extracellular volume; EF, ejection fraction; LV, left ventricular; NT-proBNP, N-terminal pro–B-type natriuretic peptide; blastic plasmacytoid dendritic cell neoplasm; capillary leak syndrome; myocardial edema; tagraxofusp.

Publication types

Review